Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

459 results about "Appetite" patented technology

Appetite is the desire to eat food, sometimes due to hunger. Appealing foods can stimulate appetite even when hunger is absent, although appetite can be greatly reduced by satiety. Appetite exists in all higher life-forms, and serves to regulate adequate energy intake to maintain metabolic needs. It is regulated by a close interplay between the digestive tract, adipose tissue and the brain. Appetite has a relationship with every individual's behavior. Appetitive behaviour also known as approach behaviour, and consummatory behaviours, are the only processes that involve energy intake, whereas all other behaviours affect the release of energy. When stressed, appetite levels may increase and result in an increase of food intake. Decreased desire to eat is termed anorexia, while polyphagia (or "hyperphagia") is increased eating. Dysregulation of appetite contributes to anorexia nervosa, bulimia nervosa, cachexia, overeating, and binge eating disorder.

Compositions and compounds containing beta-hydroxybutyrate and one or more amino acids

Compositions and methods for administering ketone bodies to a subject include beta-hydroxybutyrate complexed with or coupled to at least one amino acid. The compositions and methods cause one or more of: weight loss, weight maintenance, reduced blood glucose level, maintenance of blood glucose level, increased muscle and physical performance, enhanced metabolic and cellular repair, improved detoxification and gut health, targeted bioavailability, sustained release and controlled absorption, increased metabolic efficiency, enhanced cellular uptake, minimized side effects, multifunctional therapeutics, improved focus, improved energy, improved cognitive function, improved mental acuity, treatment of traumatic brain injury, treatment of diabetes, treatment of neurological disorder, treatment of cancer, treatment of inflammatory condition, appetite suppression, anti-aging effects, anti-glycation effects, treatment of epilepsy, treatment of depression, improved performance, improved muscle mass, improved motor function, increased strength, increased metabolism, increased fat loss, increased fat oxidation, improved body composition, and improved mood.
Owner:AXCESS GLOBAL SCIENCES LLC

Formula of pet food for strengthening intestines and balancing nutrition for pets

The invention relates to the technical field of pet food, and particularly discloses a pet food formula for strengthening intestines and balancing nutrition for pets, the pet food formula comprises the following raw materials: meat, vegetables, fruits, whole goat milk powder, Maillard reaction products, composite algae powder, yucca powder and synbiotics microcapsules; the preparation method comprises the following steps: respectively crushing the meat, the vegetables and the fruits; stirring and mixing the meat paste, the vegetable paste, the fruit paste, the whole goat milk powder, the composite algae powder, the yucca powder and the synbiotics microcapsules to obtain a mixed material; placing the mixed material in an extruder to prepare cylindrical particles; spraying the Maillard reaction product on the surfaces of the particles by adopting vacuum spraying equipment; the sprayed particles are fed into a freeze-drying bin to be freeze-dried; and packaging the frozen freeze-dried particles into bags to obtain the pet food capable of strengthening the intestines and being balanced in nutrition. The formula of the pet food capable of strengthening the intestines and balancing the nutrition has remarkable effects in the aspects of improving the health of the intestines, guaranteeing the balanced nutrition, improving the appetite of the pets and the like.
Owner:深圳海珹科技有限公司

Long-acting polypeptide analogue and application thereof

The invention discloses a long-acting polypeptide analogue and application thereof, the polypeptide analogue can act on a GLP-1 receptor, a GIP receptor and a Y2 receptor at the same time, and can play the biological activities of GLP-1, GIP and PYY3-36 at the same time; the PYY3-36 GLP-1 has the treatment effect of GLP-1 on diabetes mellitus, also has the beneficial effect of GIP on glucose and lipid metabolism and appetite inhibition, and also has the beneficial effect of PYY3-36 on appetite inhibition, so that the PYY3-36 GLP-1 has a synergistic effect on glucose, lipid and energy metabolism; the application of the compound in preparation of drugs for treating metabolic syndromes, such as diabetes, obesity and dyslipidemia, has greater potential in preparation of drugs for treating diseases such as diabetes, obesity and dyslipidemia.
Owner:XUZHOU MEDICAL UNIVERSITY

Sugar-controlling and fat-reducing composition for satiety as well as preparation method and application of sugar-controlling and fat-reducing composition

The invention discloses a satiety sugar-controlling fat-reducing composition and a preparation method and application thereof, the satiety sugar-controlling fat-reducing composition comprises hydrogel particles, a white kidney bean extract, a mulberry leaf extract, alpha-lipoic acid, L-carnitine, a lotus leaf extract, medium chain triglyceride, polyethylene glycol and sorbitol, and the composition is a tablet. The components are matched with one another to effectively adjust the leptin level, improve appetite, increase energy consumption, adjust the fat metabolism process, reduce fat accumulation, improve fat consumption, inhibit the activity of alpha-amylase, reduce the conversion of carbohydrates into fat, block heat and fat intake, promote gastrointestinal motility and enhance the immunity of the human body. The effects of remarkably reducing the fat content and the body weight are achieved.
Owner:SHANGHAI PANDA MEDICAL CO LTD +1

Health-care product with weight-losing effect as well as preparation method and application of health-care product

The invention discloses a health-care product with a weight-losing effect as well as a preparation method and application of the health-care product. The health-care product is prepared from the following raw materials in parts by weight: 1-5 parts of an aloe extract, 5-10 parts of an acanthopanax sessiliflorus leaf extract, 20-30 parts of pigeon pea natto powder and 40-60 parts of auxiliary materials. Research finds that the aloe extract, the acanthopanax sessiliflorus leaf extract and the pigeon pea natto powder are combined to play an obvious weight-losing role in the aspects of inhibiting lipase activity, regulating lipid metabolism, increasing energy consumption, controlling appetite and the like; by using the pigeon pea natto powder, the diarrhea phenomenon caused by the aloe extract and the acanthopanax sessiliflorus leaf extract can be obviously reduced. The three components and a proper amount of auxiliary materials are compounded to prepare the health-care product, and the health-care product can be used for reducing blood sugar, reducing lipid and losing weight and has the advantages of being natural, green, safe in property, remarkable in effect and small in side effect.
Owner:GUANGZHOU SEAGREEN BIOTECHNOLOGY CO LTD

Intestinal insulinotropic analogue with multiple biological activities, synthetic method, pharmaceutical composition and application

The invention relates to the technical field of biological medicine, and discloses an intestinal insulinotropic analogue with multiple biological activities, a synthesis method, a pharmaceutical composition and application, the synthesized intestinal insulinotropic analogue has triple agonist activity of a GLP-1 receptor, a glucagon receptor and a CCK-1 receptor, not only has the treatment effect of GLP-1 on diabetes, but also has the treatment effect of GLP-1 on CCK-1, and also has the effect of GLP-1 on CCK-1 on CCK-1. The traditional Chinese medicine composition also has the regulating effect of glucagon on lipolysis and energy metabolism and the beneficial effect of CCK on appetite inhibition, so that a synergistic effect is generated on sugar, fat and energy metabolism; the application has great potential in preparation of drugs for treating metabolic syndromes, such as diabetes, obesity, non-alcoholic fatty liver diseases, dyslipidemia and other diseases.
Owner:JIANGSU FOOD & PHARMA SCI COLLEGE

Making method of Qianbei red sour soup

The present invention discloses a Qianbei red sour soup production method, which comprises: S1, sequentially washing, sterilizing and air-drying complete cherry tomatoes, adding salt and Baijiu, and carrying out sealed fermentation to obtain a material A; s2, sequentially washing, sterilizing, airing and chopping fresh chilies, adding salt and seasonings, performing sealed fermentation, taking out the chilies after fermentation is mature, and grinding the chilies into slurry to obtain a material B; s3, cooking and concentrating the soup-stock until the water content is lower than 2% to obtain a material C; and S4, uniformly stir-frying the material A, the material B and the material C in hot oil, cooling to room temperature, and sterilizing to obtain the red sour soup. The method can effectively lock the sour fragrance of the red sour soup (especially cherry tomatoes), ensures that the red sour soup keeps fragrance for a long time, is suitable for large-scale commercial production, and the prepared red sour soup can continuously release the sour fragrance when being eaten, is strong in sour fragrance, unique in flavor and good in taste, can obviously increase appetite, and has a good market prospect. The fragrance and flavor are much higher than those of red sour soup prepared by a traditional process.
Owner:ZUNYI ZUOAN FISHING VILLAGE CATERING SERVICE CO LTD

EGCG (epigallocatechin gallate) and lycopene co-loaded low-fat plant-based fat as well as preparation method and application thereof

The invention discloses a preparation method and application of low-fat plant-based fat co-loaded with EGCG (epigallocatechin gallate) and lycopene, and belongs to the technical field of fat product processing. The W / O / W and O / W / O type emulsion gel fats which have different fat properties and are co-loaded with EGCG and lycopene can be prepared, the preparation process is simple, the stabilizer is natural and green, efficient co-loading of hydrophilic EGCG and lipophilic lycopene is achieved, the fat digestibility of the plant-based fat can be controlled by regulating the structure and fat content of the plant-based fat, and the stability of the plant-based fat is improved. The product can be used for developing low-fat healthy non-dairy cream, ice cream, mayonnaise, custard sauce and other products; besides, degradation protection and fixed-point release of EGCG and lycopene can be achieved, bioavailability of EGCG and lycopene is improved, synergistic anti-inflammatory biological activity is shown, and development and manufacturing of novel nutrition-enriched fat-like and plant-based healthy fat products are greatly promoted.
Owner:JIANGNAN UNIV

GLP-1, GIP and GCG triple receptor agonist as well as preparation method and application thereof

The invention relates to the technical field of polypeptide drugs for metabolic diseases, in particular to a glucagon-like peptide (GLP-1), a glucose-dependent insulinotropic polypeptide (GIP) and a glucagon (GCG) triple receptor agonist (protein). According to the triple receptor agonist protein provided by the technical scheme, weight reduction is achieved, meanwhile, lower side effects are shown, and drug compliance is enhanced. The triple receptor stimulant researched and developed by the technical scheme can be applied to preparation of medicines with the effects of losing weight, reducing lipid or reducing blood sugar, solves the technical problem that the existing GLP-1, GIP and GCG triple receptor stimulants are difficult to reduce side effects while reducing body weight, and breaks through the weight loss mode that the traditional medicines depend on appetite suppression; due to the unique action mechanism and good safety, a safer and more effective treatment scheme is provided for patients, and the medicine has wide market prospects and social benefits.
Owner:LEPU JIANTANG PHARMACEUTICAL (CHONGQING) CO LTD

Composition for relieving gastrointestinal reaction and enhancing appetite after chemotherapy in cancer patient

The invention discloses a composition for relieving gastrointestinal reaction and enhancing appetite of cancer patients after chemotherapy, and relates to a composition for relieving gastrointestinal reaction and enhancing appetite. The invention aims to solve the problem of strong gastrointestinal reaction of cancer patients after chemotherapy. The composition for relieving gastrointestinal reaction and enhancing appetite after chemotherapy of cancer patients is prepared from ganoderma capense and coriolus versicolor polysaccharide fermentation products, phellinus igniarius polyphenol extracts and phellinus pini and ginseng flower water extracts according to the mass ratio of 1: 1: 1. The composition disclosed by the invention can be used for improving the anti-cancer effect in a mouse body. The traditional Chinese medicine composition not only can improve the immune function of the body and improve appetite, but also can change the immune microenvironment of the body and enhance the immune function of the body. The invention belongs to the technical field of relieving gastrointestinal reactions of cancer patients after chemotherapy.
Owner:HEILONGJIANG ACAD OF TCM

Hydrogel material composition, and weight management composition, preparation method therefor and use thereof

The present invention relates to the technical field of food and drugs, and in particular to a hydrogel material composition, and a weight management composition, a preparation method therefor and a use thereof. The hydrogel material composition comprises konjac powder, galactomannan, and resistant dextrin. The weight management composition comprises the following components in parts by mass: 40-60 parts of a hydrogel material composition, 10-40 parts of a disintegrating agent, 0-15 parts of inorganic salt, and 10-35 parts of a filler. In the present invention, the composition prepared from specific components and by specific proportions can have good preparation performance, disintegration performance, and gelling performance; the product quality stability is high; the composition is suitable for large-scale application development; and the composition can occupy the space in the stomach after being eaten, so that satiety is promoted, and the appetite is reduced, thereby achieving the purposes of realizing weight management, blood sugar control and the like.
Owner:SHANGHAI SCIZENG MEDICAL TECH CO LTD

Insulin analogue and application thereof

The invention discloses an intestinal insulinotropic analogue and application thereof, the intestinal insulinotropic analogue can simultaneously act on a GLP-1 receptor, a glagon receptor and a GIP receptor, and can simultaneously play the activities of the GLP-1, the glagon and the GIP; according to the present invention, the GLP-1 has the diabetes treatment effect, the glucagon has the beneficial effects of weight, energy metabolism and lipid metabolism, and the GIP has the beneficial effects of sugar, lipid metabolism and appetite inhibition so as to produce the synergistic effect on sugar, lipid and energy metabolism; the application of the polypeptide to preparation of drugs for treating metabolic syndromes, such as diabetes, dyslipidemia, fatty liver diseases, obesity and the like, has greater potential.
Owner:XUZHOU MEDICAL UNIVERSITY

Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a KATP channel opener

This invention relates to treating Prader-Willi Syndrome (PWS) using a KATP channel opener. The channel opener may be coadministered with other therapies used to treat PWS, such as human growth hormone, a wakefulness promoting agent, or a psychiatric or mood stabilizing drug, thereby allowing the baseline dosages of these other therapies to be decreased or making these other therapies unnecessary. The invention also relates to treating PWS based on the PWS nutritional phase of a patient, to prevent the patient's PWS nutritional phase from progressing or shift the patient's PWS nutritional phase back to an earlier phase. The invention further relates to treating PWS, and conditions associated with low basal metabolic rate or hyperphagia, with the KATP channel opener based on a patient's blood ketone levels.
Owner:SEDOGEN

Pure traditional Chinese medicine preparation for treating depression and preparation method thereof

The invention belongs to the field of traditional Chinese medicine preparations, and provides a pure traditional Chinese medicine preparation for treating depression and a preparation method of the pure traditional Chinese medicine preparation. The preparation method comprises the following steps: S1, weighing raw materials according to a formula, putting the raw materials into a clean container, adding water which is 8-12 times of the total weight of the raw materials, and soaking at room temperature for 1-2 hours; s2, transferring the soaked raw materials and liquid medicine into a decoction container, boiling with strong fire, then turning into slow fire, and decocting for 1.5-2.5 hours in a slightly boiling state; according to the pure traditional Chinese medicine preparation disclosed by the invention, through reasonable compatibility of various traditional Chinese medicinal materials, all the components have a synergistic effect, and the effects of soothing liver and regulating qi, strengthening spleen and harmonizing stomach, nourishing heart and tranquilizing mind, promoting blood circulation to remove blood stasis, reducing phlegm and clearing damp are jointly achieved; the pure traditional Chinese medicine preparation can effectively improve the symptoms of low mood, restless mood, insomnia and dreaminess, inappetence and hypodynamia of depression patients, and clinical practice verifies that the pure traditional Chinese medicine preparation prepared by the invention has a remarkable effect in the aspect of treating depression compared with existing conventional anti-depression western medicines.
Owner:袁高峰

Pet dog flavor agent powder and preparation method thereof

The invention relates to the technical field of pet food, in particular to flavoring agent powder for pet dogs and a preparation method of the flavoring agent powder. Comprising the following raw materials: 40 parts of beef liver, 10 parts of hairtail, 7-40 parts of ricefield eel, 1 part of protease, 0.5-1 part of lipase, 0.5-1 part of flavor enzyme, 5-10 parts of saccharides, 10 parts of fish oil, 5-10 parts of maltodextrin, 0.5-1 part of sodium hydroxide, 5 parts of phosphoric acid, 3 parts of amino acid, 2 parts of thiamine, 1 part of yeast extract and 0.5-1 part of lactoferrin. The dog feed can increase the appetite of dogs from the sense of smell, maintain the health balance of intestinal flora of dogs and improve the micro-ecological environment of intestinal tracts.
Owner:SHANDONG PAILERT BIOTECHNOLOGY CO LTD

Processing method of flavored radishes

The present invention provides a flavored radish processing method, which comprises: (1) screening, washing, trimming and slicing a radish raw material to obtain radish slices; (2) soaking the radish slices in a crispness-keeping solution for crispness-keeping treatment to obtain crispness-kept radish slices; (3) sequentially performing marinating and boiling treatment, draining, cooling and vacuum packaging on the crisp-keeping radish slices to obtain a flavored radish prefabricated bag; and (4) performing sterilization treatment and post-treatment on the flavored radish prefabricated bag to obtain the flavored radish. The processing method provided by the invention can keep the radish sweet and white, soft and glutinous in biting feeling, tasty and juicy, and complete in appearance, and the nutrition is not lost; in addition, the flavored radish can be stored at normal temperature, is ready-to-eat, can be used as a staple food dish, also can be used as a leisure food, can be matched with instant food for eating, is delicious and tasty, can promote appetite, and has a very wide market prospect.
Owner:UNI PRESIDENT ENTERPRISES CHINA INVESTMENT CO LTD KUNSHAN RES & DEV CENT +1

Methods of treatment using a leptin receptor agonist antibody

ActiveUS12371503B2Obesity gene productsMetabolism disorderAntigenDyslipidemia
Provided herein are therapeutic methods of treatment using agonist leptin receptor (LEPR) antibodies, antigen-binding fragments thereof, or compositions comprising the LEPR antibodies or antigen-binding fragments thereof. Such therapeutic methods include treatment for conditions related to metabolic dysfunction, including for example, lipodystrophy, adiposity or obesity, reducing body weight, non-alcoholic fatty liver disease, hyperphagia, hyperglycemia, insulin resistance, dyslipidemia, hepatic steatosis, and infertility.
Owner:REGENERON PHARMACEUTICALS INC

Durnella, extracellular polysaccharide produced by same and application of extracellular polysaccharide

The invention discloses a Dunella strain, polysaccharide produced by the Dunella strain and application of the Dunella strain. The preservation number of the Duronella G3 is CCTCC (China Center For Type Culture Collection) NO: M 2024137, and the exopolysaccharide TDG3 produced by the Duronella G3 is used as a TLR4 / DC-SIGN dual receptor agonist and has the effect of remarkably reducing body weight. The exopolysaccharide TDG3 disclosed by the invention can obviously reduce the appetite of mice, reduce the food intake, reduce the body weight and reduce the content of adipose tissues, can also relieve or prevent liver fatty degeneration caused by obesity, is safe and non-toxic, is suitable for preparing the medicines for reducing fat and losing weight, and has a relatively good clinical application value and a wide application prospect.
Owner:NANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD

Probiotics and methods to reduce appetite

Provided herein are methods and compositions related to reducing appetite. In some aspects, provided herein are methods of reducing appetite in a subject by administering to the subject a composition comprising Parabacteroides and Akkermansia bacteria.
Owner:BLOOM SCIENCE INC

Methods of treatment using a leptin receptor agonist antibody

PendingUS20250320301A1Obesity gene productsMetabolism disorderAntigenDyslipidemia
Provided herein are therapeutic methods of treatment using agonist leptin receptor (LEPR) antibodies, antigen-binding fragments thereof, or compositions comprising the LEPR antibodies or antigen-binding fragments thereof. Such therapeutic methods include treatment for conditions related to metabolic dysfunction, including for example, lipodystrophy, adiposity or obesity, reducing body weight, non-alcoholic fatty liver disease, hyperphagia, hyperglycemia, insulin resistance, dyslipidemia, hepatic steatosis, and infertility.
Owner:REGENERON PHARMACEUTICALS INC

A traditional Chinese medicine for treating late stage of respiratory virus infection

The present invention relates to a Chinese medicine for treating late respiratory viral infection, wherein the Chinese medicine comprises the following raw materials in weight proportions: 280-350 parts of Pseudostellariae Radix, 100-140 parts of Cinnamon Twig, 130-170 parts of White Peony Root, 130-170 parts of Poria, 130-170 parts of Atractylodes Macrocephala, 280-340 parts of Shenqu, 100-140 parts of Morus Album, 100-140 parts of Trichosanthes, 130-170 parts of Houttuynia Cordata, 100-140 parts of Platycodon, 100-140 parts of Fritillariae Thunbergii, and 50-70 parts of Licorice. The prescription has the functions of invigorating Qi and nourishing Yin, clearing away heat and resolving phlegm. It is mainly used for treating the late stage of new coronavirus infection, influenza, common cold, etc., which are caused by disharmony between Ying and Wei, consumption of Qi and injury to Yin, physical weakness, fatigue, spontaneous sweating, fear of wind, cough and sputum, dry throat and sore throat, loss of appetite, pale red tongue, thin white or yellow fur, and floating and weak pulse. The traditional Chinese medicine is easy to take, has significant clinical efficacy, and a simple preparation process, and has a good market application prospect.
Owner:SHAANXI PROVINCIAL HOSPITAL OF CHINESE MEDICINE

Thymol derivative as well as preparation method and application thereof

The invention provides a thymol derivative as well as a preparation method and application thereof, and relates to the technical field of biological medicines. The preparation method comprises the following steps: carrying out esterification reaction on thymol and indole-3-carboxylic acid to prepare a thymol derivative, namely 2-isopropyl-5-methyl phenyl 1H-indole-3-carboxylic ester. Under the process conditions provided by the invention, the yield of the thymol derivative can reach 93-94%. The anti-coccidiosis index of the thymol derivative is as high as 196.51, and the thymol derivative can obviously reduce the influence of chicken coccidiosis on the weight of chicken, has a remarkable effect of promoting the growth and development of the body, and can obviously improve the clinical symptoms of chicken infected with coccidiosis, recover the mental condition and appetite of sick chicken, obviously reduce the occurrence of bloody stool and improve the intestinal tract lesion condition; the anti-coccidiosis effect of the thymol derivative provided by the invention is obvious and is obviously better than that of thymol, and the thymol derivative is expected to become a new veterinary drug for treating chicken coccidiosis infection.
Owner:ZHENGZHOU SHENGKAI BIOTECHNOLOGY CO LTD +1

Nutritional composition capable of regulating appetite and body weight of people after chemotherapy and improving taste perception capability and application of nutritional composition

PendingCN120283837AMilk preparationDigestive systemDecreased body weightNutrition
The invention discloses a nutritional composition capable of regulating appetite and body weight of people after chemotherapy and improving taste perception capability and application thereof. The nutritional composition provided by the invention contains milk powder, soybean protein, concentrated whey protein, bovine colostrum powder, hydrolyzed yolk, a red bean extract, a Chinese date extract, lily freeze-dried powder, broccoli freeze-dried powder, a radish seed extract, a peach kernel extract, xanthan gum and Arabic gum. The food can obviously increase appetite of people after chemotherapy and restore weight, and is helpful for treating or improving symptoms such as inappetence, weight loss and weakness of chemotherapy patients. When being applied to paclitaxel (PTX)-induced taste disorder model animals, the paclitaxel protein can improve the taste perception capability, increase the cross sectional area of a taste bud, remarkably repair taste structural damage, reduce the level of proinflammatory factors in serum and relieve hepatotoxicity caused by a chemotherapeutic drug PTX; and moreover, the water solubility and the stability are better, adhesion and layering are avoided, and stable storage is facilitated.
Owner:SHENZHEN BAOAN DISTRICT TRADITIONAL CHINESE MEDICINE HOSPITAL

Capsule oral feeding device

The invention discloses a capsule oral feeding device, relates to the field of oral feeding devices, solves the problem that the existing oral feeding tubes are mostly made of polyurethane materials, have shapes and structures similar to those of gastric tubes, but are shorter in length than gastric tubes, are made of harder materials, and are very uncomfortable for patients during use. The device comprises a first oral feeding injection tube, which is soft, has an injection structure at one end thereof, and has a quick-dissolving capsule that can be swallowed into the esophagus by the patient at the other end thereof; the patient can swallow the quick-dissolving capsule and the first oral feeding injection tube into the esophagus by himself through the remaining swallowing ability, and after entering the esophagus, the quick-dissolving capsule and the first oral feeding injection tube are unfolded to form a channel, and a fluid diet can be injected through the channel; when using the device, the patient can first eat orally to satisfy the appetite and exercise the chewing and swallowing functions; after fatigue, the capsule oral feeding tube is used to complete the calorie intake of the meal, thereby improving the comfort of the patient.
Owner:SECOND MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL

Formula and preparation method of pandan wine

The formula comprises the following raw materials in parts by weight: 70-85 parts of base liquor, 5-15 parts of fresh pandan leaves, 0.5-3 parts of baked pandan leaf powder, 1-3 parts of a flavor modifier, 3-8 parts of a sugar source and 0.1-0.6 part of a functional additive. The unique flavor of the pandan leaves originates from the rich 2-acetyl-1-pyrroline, and the pandan leaves give out charming rice dumpling fragrance and have the effects of promoting appetite and metabolism at the same time. The pandan leaves are blended into the food, so that the delicious taste is improved, and additional nutritional value is also brought. The pandan leaves are rich in dietary fibers, vitamin B family, vitamin C and various minerals. The composition also contains squalene, linoleic acid, estragole, phytol and other active ingredients. Squalene is a natural organic terpenoid, widely exists in a living body, and has remarkable effects in the aspects of promoting blood circulation, resisting oxidation, resisting inflammation, resisting tumors and the like. The prepared pandan wine has multiple effects and is beneficial to body health after being drunk for a long time.
Owner:ZHANJIANG EXPERIMENTAL STATION CHINESE ACAD OF TROPICAL AGRI SCI +1

Methods and compositions for reducing body weight in mammals

PendingUS20250345379A1Organic active ingredientsPeptide/protein ingredientsCarbohydrate absorptionPhysiology
Methods and compositions promote weight loss in mammals, such as in humans and / or animals, such as, for example, pets. Specifically, the methods and compositions herein promote weight loss due to the production of appetite-suppressing gut hormones, increased metabolism, reduced fat and carbohydrate absorption, and reduced fat deposition through the synergistic combination of fibers and botanical extracts. Food products comprising the compositions herein provide a natural and effective means of controlling appetite and managing weight.
Owner:LAFOND DAVID +1

Traditional Chinese medicine composition for alleviating gastrointestinal toxicity caused by chemotherapy

ActiveCN116942748BDispersion deliveryDigestive systemGastrointestinal toxicityMedicinal herbs
A traditional Chinese medicine composition for alleviating gastrointestinal toxic side effects caused by chemotherapy, the traditional Chinese medicine composition for daily administration is prepared from the following weight ratio of traditional Chinese medicine formula: Taizishen 20-30g, Fuling 10-15g, Fried Baizhu 10-15g, Zhigancao 5-10g, Jiangbanxia 5-10g, Chenpi 5-15g. The formula can effectively alleviate the gastrointestinal toxic side effects caused by chemotherapy, such as nausea, vomiting, diarrhea, poor appetite, etc.
Owner:XIYUAN HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI

UPLC (Ultra Performance Liquid Chromatography) detection method and fingerprint spectrum of traditional Chinese medicine preparation for tonifying spleen,

The invention relates to a spleen-tonifying, appetite-stimulating and digestion-promoting traditional Chinese medicine preparation UPLC detection method and a fingerprint spectrum, and belongs to the technical field of medicine detection. The invention aims to solve the technical problems that the existing quality control method of the spleen-tonifying, appetite-promoting and digestion-promoting pills lacks comprehensive and objective analysis on the spleen-tonifying, appetite-promoting and digestion-promoting pills, and the problems of low precision, poor reproducibility, low efficiency and the like during detection of related components in the prior art are solved. According to the technical scheme, the UPLC detection method is characterized in that a mixed standard substance of gallic acid, 5-hydroxymethylfurfural, chlorogenic acid, sinapine thiocyanate, sinapic acid, hyperoside, 3, 6-dimustard acyl sucrose, hesperidin, naringenin, nobiletin and hesperetin is taken as a contrast, an acetonitrile-0. 1% formic acid aqueous solution is taken as a mobile phase, gradient elution is carried out, and the content of chlorogenic acid in the sample is detected. The qualitative and quantitative detection of the effective components of the spleen-tonifying, appetite-promoting and digestion-promoting pill is realized.
Owner:THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM

Pharmaceutical combinations and uses thereof

The present invention relates to pharmaceutical combinations for treating or preventing insulin resistance and associated disorders, in particular the use combinations comprising a 4-epimerase inhibitor and a GLP-1 receptor agonist for treating or preventing insulin resistance and associating disorders such as obesity and type-2 diabetes, supressing appetite and / or promoting weight loss.
Owner:UNIVERSITY OF MELBOURNE

Salvianolic acid derivative and its application in drugs for treating cancer cachexia

The present invention belongs to the field of pharmaceutical synthesis, and specifically relates to salviphorol derivatives and their application in drugs for treating cancer cachexia. Salviphorol compounds include compounds represented by formula (X) and / or formula (Y), or pharmaceutically acceptable salts or optical isomers of the compounds represented by formula (X) and / or formula (Y). The present invention also provides a pharmaceutical composition for treating cachexia diseases, and its application in the preparation of drugs for treating cancer cachexia, including muscle atrophy caused by tumor tissues, fat reduction caused by tumor tissues, reduced appetite caused by tumor tissues, inflammatory responses caused by tumor tissues, and cancer cachexia caused by digestive tract-related cancers, liver cancer, lung cancer, and colon cancer. The present invention also provides its application in the preparation of drugs or inhibitors for treating or inhibiting muscle atrophy, drugs or inhibitors for inhibiting or alleviating adipocyte lipolysis, and drugs or inhibitors for inhibiting or alleviating weight loss or reduction.
Owner:SICHUAN UNIVERSITY OF SCIENCE AND ENGINEERING +1